{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:11:13Z","timestamp":1790136673583,"version":"4.0.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-025-01745-0","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T08:38:09Z","timestamp":1764578289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Interconnection between myasthenia gravis and type 2 diabetes: emerging role of metformin in modulating PI3K\/AKT\/mTOR\/AMPK axis"],"prefix":"10.1007","volume":"40","author":[{"given":"Ahmed salem","family":"Al-Dhahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3097-2962","authenticated-orcid":false,"given":"Hayder M.","family":"Al-Kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Albuhadily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya M.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber","family":"El-Saber Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"issue":"7","key":"1745_CR1","doi-asserted-by":"publisher","first-page":"e70067","DOI":"10.1111\/ejn.70067","volume":"61","author":"AA Abulaban","year":"2025","unstructured":"Abulaban AA, Al-Kuraishy HM, Al-Gareeb AI, Ahmed EA, Alruwaili M, Alexiou A, Papadakis M, Batiha E-S, G (2025) The possible role of Metformin and fibroblast growth Factor-21 in multiple sclerosis neuropathology: birds of a feather flock together. Eur J Neurosci 61(7):e70067. https:\/\/doi.org\/10.1111\/ejn.70067","journal-title":"Eur J Neurosci"},{"issue":"4","key":"1745_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4103\/jlp.Jlp_123_19","volume":"11","author":"HM Al-Kuraishy","year":"2019","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Shams HA, Al-Mamorri F (2019) Endothelial dysfunction and inflammatory biomarkers as a response factor of concurrent coenzyme Q10 add-on Metformin in patients with type 2 diabetes mellitus. J Lab Physicians 11(4):317\u2013322. https:\/\/doi.org\/10.4103\/jlp.Jlp_123_19","journal-title":"J Lab Physicians"},{"issue":"4","key":"1745_CR3","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s10787-023-01255-4","volume":"31","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Saad HM, Batiha GE (2023) The potential effect of Metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM). Inflammopharmacology 31(4):1751\u20131760. https:\/\/doi.org\/10.1007\/s10787-023-01255-4","journal-title":"Inflammopharmacology"},{"key":"1745_CR4","doi-asserted-by":"publisher","first-page":"1480950","DOI":"10.3389\/fcell.2024.1480950","volume":"12","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Abu-Alghayth MH, Albukhaty S, Jabir MS, Albuhadily AK, Al-Gareeb AI, Klionsky DJ, Abomughaid MM (2024) The role of autophagy in graves disease: knowns and unknowns. Front Cell Dev Biol 12:1480950. https:\/\/doi.org\/10.3389\/fcell.2024.1480950","journal-title":"Front Cell Dev Biol"},{"issue":"Pt 2","key":"1745_CR5","doi-asserted-by":"publisher","first-page":"142933","DOI":"10.1016\/j.ijbiomac.2025.142933","volume":"309","author":"HM Al-Kuraishy","year":"2025","unstructured":"Al-Kuraishy HM, Sulaiman GM, Mohsin MH, Mohammed HA, Dawood RA, Albuhadily AK, Al-Gareeb AI, Albukhaty S, Abomughaid MM (2025) Targeting of AMPK\/MTOR signaling in the management of atherosclerosis: outmost leveraging. Int J Biol Macromol 309(Pt 2):142933. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142933","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"1745_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22243","volume":"85","author":"Z Al-Qahtani","year":"2024","unstructured":"Al-Qahtani Z, Al-Kuraishy HM, Ali NH, Elewa YHA, Batiha GE (2024) Kynurenine pathway in type 2 diabetes: role of metformin. Drug Dev Res 85(5):e22243. https:\/\/doi.org\/10.1002\/ddr.22243","journal-title":"Drug Dev Res"},{"issue":"23","key":"1745_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70240","volume":"28","author":"YA Alanazi","year":"2024","unstructured":"Alanazi YA, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Bahaa MM, Negm WA, AlAnazi FH, Alrouji M, Batiha GE (2024) Role of autophagy in type 2 diabetes mellitus: the metabolic clash. J Cell Mol Med 28(23):e70240. https:\/\/doi.org\/10.1111\/jcmm.70240","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1745_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-024-01450-5","volume":"16","author":"NG Amin","year":"2024","unstructured":"Amin NG, Rahim AA, Rohoma K, Elwafa RAA, Dabees HMF, Elrahmany S (2024) The relation of mTOR with diabetic complications and insulin resistance in patients with type 2 diabetes mellitus. Diabetol Metab Syndr 16(1):222. https:\/\/doi.org\/10.1186\/s13098-024-01450-5","journal-title":"Diabetol Metab Syndr"},{"issue":"5","key":"1745_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1021\/acschemneuro.9b00678","volume":"11","author":"E Angelopoulou","year":"2020","unstructured":"Angelopoulou E, Paudel YN, Piperi C (2020) Unraveling the role of receptor for advanced glycation end products (RAGE) and its ligands in myasthenia gravis. ACS Chem Neurosci 11(5):663\u2013673. https:\/\/doi.org\/10.1021\/acschemneuro.9b00678","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"1745_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.nmd.2021.11.014","volume":"32","author":"HA Arroyo","year":"2022","unstructured":"Arroyo HA, Torres AR (2022) Spontaneous remission in juvenile myasthenia gravis: a cohort of 13 cases and review of the literature. Neuromuscul Disord 32(3):213\u2013219. https:\/\/doi.org\/10.1016\/j.nmd.2021.11.014","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"1745_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41387-024-00274-6","volume":"14","author":"KM Asghari","year":"2024","unstructured":"Asghari KM, Saleh P, Salekzamani Y, Dolatkhah N, Aghamohammadzadeh N, Hashemian M (2024) The effect of curcumin and high-content eicosapentaenoic acid supplementations in type 2 diabetes mellitus patients: a double-blinded randomized clinical trial. Nutr Diabetes 14(1):14","journal-title":"Nutr Diabetes"},{"issue":"2","key":"1745_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00125-021-05618-w","volume":"65","author":"JWJ Beulens","year":"2022","unstructured":"Beulens JWJ, Pinho MGM, Abreu TC, den Braver NR, Lam TM, Huss A, Vlaanderen J, Sonnenschein T, Siddiqui NZ, Yuan Z, Kerckhoffs J, Zhernakova A, Gois B, M. F., Vermeulen RCH (2022) Environmental risk factors of type 2 diabetes-an exposome approach. Diabetologia 65(2):263\u2013274. https:\/\/doi.org\/10.1007\/s00125-021-05618-w","journal-title":"Diabetologia"},{"issue":"2","key":"1745_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/mus.20746","volume":"36","author":"A Bhibhatbhan","year":"2007","unstructured":"Bhibhatbhan A, Kline G, Vincent A, Toth C (2007) Anti-MuSK myasthenia gravis presenting with Epstein-Barr virus-associated mononucleosis and immune-mediated diabetes mellitus. Muscle Nerve 36(2):264\u2013266. https:\/\/doi.org\/10.1002\/mus.20746","journal-title":"Muscle Nerve"},{"issue":"10","key":"1745_CR14","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.4161\/cc.20036","volume":"11","author":"M Blandino-Rosano","year":"2012","unstructured":"Blandino-Rosano M, Chen AY, Scheys JO, Alejandro EU, Gould AP, Taranukha T, Elghazi L, Cras-M\u00e9neur C, Bernal-Mizrachi E (2012) Mtorc1 signaling and regulation of pancreatic \u03b2-cell mass. Cell Cycle 11(10):1892\u20131902. https:\/\/doi.org\/10.4161\/cc.20036","journal-title":"Cell Cycle"},{"issue":"1\u20132","key":"1745_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.neures.2013.07.008","volume":"77","author":"M Chauhan","year":"2013","unstructured":"Chauhan M, Punga T, Punga AR (2013) Muscle-specific regulation of the mTOR signaling pathway in MuSK antibody seropositive (MuSK+) experimental autoimmune myasthenia gravis (EAMG). Neurosci Res 77(1\u20132):102\u2013109. https:\/\/doi.org\/10.1016\/j.neures.2013.07.008","journal-title":"Neurosci Res"},{"issue":"4","key":"1745_CR16","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.bbrc.2015.01.034","volume":"457","author":"S Chen","year":"2015","unstructured":"Chen S, Zhou N, Zhang Z, Li W, Zhu W (2015) Resveratrol induces cell apoptosis in adipocytes via AMPK activation. Biochem Biophys Res Commun 457(4):608\u2013613","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1745_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.17305\/bb.2024.11197","volume":"25","author":"J Chen","year":"2025","unstructured":"Chen J, Lu J, Lv Z, Wang B, Zhang S, Xu P, Wang J (2025) Mitochondrial dysfunction in myasthenia gravis: exploring directions for future immunotherapy? A review. Biomol Biomed 25(2):346\u2013359. https:\/\/doi.org\/10.17305\/bb.2024.11197","journal-title":"Biomol Biomed"},{"issue":"8","key":"1745_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13082273","volume":"13","author":"CG Croitoru","year":"2024","unstructured":"Croitoru CG, Pavel-Tanasa M, Cuciureanu DI, Hodorog DN, Cianga P (2024) Autoimmune and non-autoimmune comorbidities in myasthenic patients of East-European descent: a case\u2013control study. J Clin Med 13(8):2273","journal-title":"J Clin Med"},{"key":"1745_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105822","volume":"75","author":"Y Cui","year":"2019","unstructured":"Cui Y, Chang L, Wang C, Han X, Mu L, Hao Y, Liu C, Zhao J, Zhang T, Zhang H, Zhang Y, Liu Y, Zhao W, Wang J, Liu X, Sun B, Wang G, Kong Q, Han J, Li H (2019) Metformin attenuates autoimmune disease of the neuromotor system in animal models of myasthenia gravis. Int Immunopharmacol 75:105822. https:\/\/doi.org\/10.1016\/j.intimp.2019.105822","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"1745_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-018-1049-6","volume":"18","author":"EM Desjardins","year":"2018","unstructured":"Desjardins EM, Steinberg GR (2018) Emerging role of AMPK in brown and beige adipose tissue (BAT): implications for obesity, insulin resistance, and type 2 diabetes. Curr Diab Rep 18(10):80. https:\/\/doi.org\/10.1007\/s11892-018-1049-6","journal-title":"Curr Diab Rep"},{"key":"1745_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00575","volume":"9","author":"GL Dornan","year":"2018","unstructured":"Dornan GL, Burke JE (2018) Molecular mechanisms of human disease mediated by oncogenic and primary immunodeficiency mutations in class IA phosphoinositide 3-kinases. Front Immunol 9:575. https:\/\/doi.org\/10.3389\/fimmu.2018.00575","journal-title":"Front Immunol"},{"key":"1745_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112235","author":"L Dresser","year":"2021","unstructured":"Dresser L, Wlodarski R, Rezania K, Soliven B (2021) Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10112235","journal-title":"J Clin Med"},{"key":"1745_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00701","volume":"11","author":"X Duan","year":"2020","unstructured":"Duan X, Sun P, Lan Y, Shen C, Zhang X, Hou S, Chen J, Ma B, Xia Y, Su C (2020) IFN-\u03b1 modulates memory Tfh cells and memory B cells in mice, following recombinant FMDV adenoviral challenge. Front Immunol 11:701. https:\/\/doi.org\/10.3389\/fimmu.2020.00701","journal-title":"Front Immunol"},{"issue":"4","key":"1745_CR24","doi-asserted-by":"publisher","first-page":"e70155","DOI":"10.1002\/prp2.70155","volume":"13","author":"J Elford","year":"2025","unstructured":"Elford J, O\u2019Reilly RJ, Babey AM, Rafeek RAM, Ketheesan N (2025) Sulphonylureas as adjunct therapeutic agents in the treatment of autoimmune conditions: A narrative review. Pharmacol Res Perspect 13(4):e70155. https:\/\/doi.org\/10.1002\/prp2.70155","journal-title":"Pharmacol Res Perspect"},{"issue":"3","key":"1745_CR25","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.cmet.2013.02.008","volume":"17","author":"Y Fang","year":"2013","unstructured":"Fang Y, Westbrook R, Hill C, Boparai RK, Arum O, Spong A, Wang F, Javors MA, Chen J, Sun LY, Bartke A (2013) Duration of Rapamycin treatment has differential effects on metabolism in mice. Cell Metab 17(3):456\u2013462. https:\/\/doi.org\/10.1016\/j.cmet.2013.02.008","journal-title":"Cell Metab"},{"key":"1745_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.970292","volume":"13","author":"C Fang","year":"2022","unstructured":"Fang C, Pan J, Qu N, Lei Y, Han J, Zhang J, Han D (2022) The AMPK pathway in fatty liver disease. Front Physiol 13:970292. https:\/\/doi.org\/10.3389\/fphys.2022.970292","journal-title":"Front Physiol"},{"issue":"16","key":"1745_CR27","doi-asserted-by":"publisher","first-page":"e1594","DOI":"10.1212\/wnl.0000000000207642","volume":"101","author":"CEH Fang","year":"2023","unstructured":"Fang CEH, Bokre D, Wong SH (2023) Clinical characteristics associated with secondary generalization in patients with ocular myasthenia gravis: A systematic review and Meta-analysis. Neurology 101(16):e1594\u2013e1605. https:\/\/doi.org\/10.1212\/wnl.0000000000207642","journal-title":"Neurology"},{"issue":"7","key":"1745_CR28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.it.2022.04.013","volume":"43","author":"A Fert","year":"2022","unstructured":"Fert A, Marchand LR, Salinas TRW, Ancuta P (2022) Targeting Th17 cells in HIV-1 remission\/cure interventions. Trends Immunol 43(7):580\u2013594","journal-title":"Trends Immunol"},{"issue":"26","key":"1745_CR29","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.1021\/acs.jafc.5b01238","volume":"63","author":"Y Gao","year":"2015","unstructured":"Gao Y, Zhang M, Wu T, Xu M, Cai H, Zhang Z (2015) Effects of d-pinitol on insulin resistance through the PI3K\/Akt signaling pathway in type 2 diabetes mellitus rats. J Agric Food Chem 63(26):6019\u20136026. https:\/\/doi.org\/10.1021\/acs.jafc.5b01238","journal-title":"J Agric Food Chem"},{"issue":"2","key":"1745_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1536\/ihj.20-315","volume":"62","author":"J Gao","year":"2021","unstructured":"Gao J, Feng W, Lv W, Liu W, Fu C (2021) HIF-1\/AKT signaling-activated PFKFB2 alleviates cardiac dysfunction and cardiomyocyte apoptosis in response to hypoxia. Int Heart J 62(2):350\u2013358. https:\/\/doi.org\/10.1536\/ihj.20-315","journal-title":"Int Heart J"},{"key":"1745_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14124221","author":"V Giannopapas","year":"2025","unstructured":"Giannopapas V, Stefanou MI, Zouvelou V, Papagiannopoulou G, Smyrni V, Kosmidou M, Kitsos DK, Keramida A, Salakou S, Tsivgoulis G, Tzartos JS, Giannopoulos S (2025) Risk of diabetes mellitus in the myasthenia gravis: a systematic review and meta-analysis. J Clin Med. 14(12):4221.\u00a0https:\/\/doi.org\/10.3390\/jcm14124221","journal-title":"J Clin Med"},{"issue":"9","key":"1745_CR33","doi-asserted-by":"publisher","first-page":"e46082","DOI":"10.7759\/cureus.46082","volume":"15","author":"D Gosain","year":"2023","unstructured":"Gosain D, Das T (2023) Myasthenia Gravis presenting as bulbar palsy. Cureus 15(9):e46082. https:\/\/doi.org\/10.7759\/cureus.46082","journal-title":"Cureus"},{"issue":"12","key":"1745_CR34","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.cmet.2024.10.004","volume":"36","author":"V Gray","year":"2024","unstructured":"Gray V, Chen W, Tan RJY, Teo JMN, Huang Z, Fong CH-Y, Law TWH, Ye Z-W, Yuan S, Bao X (2024) Hyperglycemia-triggered lipid peroxidation destabilizes STAT4 and impairs anti-viral Th1 responses in type 2 diabetes. Cell Metabol 36(12):2511\u20132527 e2517","journal-title":"Cell Metabol"},{"issue":"2","key":"1745_CR35","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000207863","volume":"102","author":"AA Habib","year":"2024","unstructured":"Habib AA, Sacks N, Cool C, Durgapal S, Dennen S, Everson K, Hughes T, Hernandez J, Phillips G (2024) Hospitalizations and mortality from myasthenia gravis: trends from 2 US national datasets. Neurology 102(2):e207863. https:\/\/doi.org\/10.1212\/wnl.0000000000207863","journal-title":"Neurology"},{"key":"1745_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.imlet.2022.09.002","volume":"250","author":"Y Hao","year":"2022","unstructured":"Hao Y, Zhao W, Chang L, Chen X, Liu C, Liu Y, Hou L, Su Y, Xu H, Guo Y, Sun Q, Mu L, Wang J, Li H, Han J, Kong Q (2022) Metformin inhibits the pathogenic functions of AChR-specific B and Th17 cells by targeting miR-146a. Immunol Lett 250:29\u201340. https:\/\/doi.org\/10.1016\/j.imlet.2022.09.002","journal-title":"Immunol Lett"},{"issue":"1","key":"1745_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s13046-024-03207-4","volume":"43","author":"D Hassan","year":"2024","unstructured":"Hassan D, Menges CW, Testa JR, Bellacosa A (2024) AKT kinases as therapeutic targets. J Exp Clin Cancer Res 43(1):313. https:\/\/doi.org\/10.1186\/s13046-024-03207-4","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1745_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01588-9","volume":"22","author":"L He","year":"2024","unstructured":"He L, Zhong Z, Wen S, Li P, Jiang Q, Liu F (2024) Gut microbiota-derived butyrate restores impaired regulatory T cells in patients with achr myasthenia gravis via mTOR-mediated autophagy. Cell Commun Signal 22(1):215. https:\/\/doi.org\/10.1186\/s12964-024-01588-9","journal-title":"Cell Commun Signal"},{"key":"1745_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jneuroim.2016.07.001","volume":"298","author":"Y Hong","year":"2016","unstructured":"Hong Y, Li HF, Skeie GO, Romi F, Hao HJ, Zhang X, Gao X, Owe JF, Gilhus NE (2016) Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia Gravis patients. J Neuroimmunol 298:51\u201357. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.07.001","journal-title":"J Neuroimmunol"},{"issue":"11","key":"1745_CR40","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/ijbs.27173","volume":"14","author":"X Huang","year":"2018","unstructured":"Huang X, Liu G, Guo J, Su Z (2018) The PI3K\/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci 14(11):1483\u20131496. https:\/\/doi.org\/10.7150\/ijbs.27173","journal-title":"Int J Biol Sci"},{"issue":"3","key":"1745_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11481-021-10030-7","volume":"17","author":"X Huang","year":"2022","unstructured":"Huang X, Zhu J, Liu T, Li F, Yang T, Li H, Chen F, Zhang Y, Wang Y, Fu L (2022) Increased expression of CD95 in CD4\u2009+\u2009effector memory T cells promotes Th17 response in patients with myasthenia gravis. J Neuroimmune Pharmacol 17(3):437\u2013452","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"1745_CR42","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/jcsm.12846","volume":"13","author":"N Jaiswal","year":"2022","unstructured":"Jaiswal N, Gavin M, Loro E, Sostre-Col\u00f3n J, Roberson PA, Uehara K, Rivera-Fuentes N, Neinast M, Arany Z, Kimball SR, Khurana TS, Titchenell PM (2022) AKT controls protein synthesis and oxidative metabolism via combined mTORC1 and FOXO1 signalling to govern muscle physiology. J Cachexia Sarcopenia Muscle 13(1):495\u2013514. https:\/\/doi.org\/10.1002\/jcsm.12846","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1745_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110482","volume":"129","author":"W Jiao","year":"2020","unstructured":"Jiao W, Hu F, Li J, Song J, Liang J, Li L, Song Y, Chen Z, Li Q, Ke L (2020) Qiangji jianli decoction promotes mitochondrial biogenesis in skeletal muscle of myasthenia gravis rats via AMPK\/PGC-1\u03b1 signaling pathway. Biomed Pharmacother 129:110482. https:\/\/doi.org\/10.1016\/j.biopha.2020.110482","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1745_CR44","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10134","volume":"22","author":"L Ke","year":"2021","unstructured":"Ke L, Li Q, Song J, Jiao W, Ji A, Chen T, Pan H, Song Y (2021) The mitochondrial biogenesis signaling pathway is a potential therapeutic target for myasthenia gravis via energy metabolism (review). Exp Ther Med 22(1):702. https:\/\/doi.org\/10.3892\/etm.2021.10134","journal-title":"Exp Ther Med"},{"issue":"1","key":"1745_CR45","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/bab.2104","volume":"69","author":"L Kma","year":"2022","unstructured":"Kma L, Baruah TJ (2022) The interplay of ROS and the PI3K\/Akt pathway in autophagy regulation. Biotechnol Appl Biochem 69(1):248\u2013264. https:\/\/doi.org\/10.1002\/bab.2104","journal-title":"Biotechnol Appl Biochem"},{"issue":"3","key":"1745_CR46","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00438-022-01878-2","volume":"297","author":"S Kong","year":"2022","unstructured":"Kong S, Cai B, Nie Q (2022) PGC-1\u03b1 affects skeletal muscle and adipose tissue development by regulating mitochondrial biogenesis. Mol Genet Genomics 297(3):621\u2013633. https:\/\/doi.org\/10.1007\/s00438-022-01878-2","journal-title":"Mol Genet Genomics"},{"key":"1745_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00212","volume":"11","author":"K Lazaridis","year":"2020","unstructured":"Lazaridis K, Tzartos SJ (2020) Autoantibody specificities in myasthenia Gravis; implications for improved diagnostics and therapeutics. Front Immunol 11:212. https:\/\/doi.org\/10.3389\/fimmu.2020.00212","journal-title":"Front Immunol"},{"issue":"9","key":"1745_CR48","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-918","volume":"8","author":"Z Li","year":"2020","unstructured":"Li Z, Peng Y, Li Y, Zhou R, Chen D, Jin W, Xu Q, Xu L, Luo Z, Yang H (2020) Glucose metabolism pattern of peripheral blood immune cells in myasthenia gravis patients. Ann Transl Med 8(9):577. https:\/\/doi.org\/10.21037\/atm-20-918","journal-title":"Ann Transl Med"},{"key":"1745_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112699","volume":"139","author":"Y Li","year":"2024","unstructured":"Li Y, Shan Y, Xu L, Chen W, Li Y (2024) Dihydroartemisinin ameliorates experimental autoimmune myasthenia gravis by regulating CD4(+) T cells and modulating gut microbiota. Int Immunopharmacol 139:112699. https:\/\/doi.org\/10.1016\/j.intimp.2024.112699","journal-title":"Int Immunopharmacol"},{"key":"1745_CR50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.molimm.2025.01.006","volume":"178","author":"X Li","year":"2025","unstructured":"Li X, Yao X, Zhao W, Wei B, Zhang R, Yan G, Ma M, Wang Z, Liu X, Liu Y, Wang G, Li H, Kong Q, Wang J, Mu L (2025) Muscle fiber types switched during the development of experimental autoimmune myasthenia gravis via the PI3K\/Akt signaling pathway. Mol Immunol 178:41\u201351. https:\/\/doi.org\/10.1016\/j.molimm.2025.01.006","journal-title":"Mol Immunol"},{"issue":"1","key":"1745_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01431-w","volume":"28","author":"J Liu","year":"2023","unstructured":"Liu J, Pan S, Wang X, Liu Z, Zhang Y (2023a) Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives. Eur J Med Res 28(1):553","journal-title":"Eur J Med Res"},{"key":"1745_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1125842","volume":"14","author":"YD Liu","year":"2023","unstructured":"Liu YD, Tang F, Li XL, Liu YF, Zhang P, Yang CL, Du T, Li H, Wang CC, Liu Y, Yang B, Duan RS (2023b) Type 2 diabetes mellitus as a possible risk factor for myasthenia gravis: a case-control study. Front Neurol 14:1125842. https:\/\/doi.org\/10.3389\/fneur.2023.1125842","journal-title":"Front Neurol"},{"issue":"2","key":"1745_CR53","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00210-023-02641-z","volume":"397","author":"Y Liu","year":"2024","unstructured":"Liu Y, Chen S, Wang Y, Zhang Z, Zhang H, Wang Z, Tao Z, Wang J, Zhang P (2024) Dexamethasone improves thymoma-associated myasthenia gravis via the AKT-mTOR pathway. Naunyn Schmiedebergs Arch Pharmacol 397(2):817\u2013828. https:\/\/doi.org\/10.1007\/s00210-023-02641-z","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1745_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111286","volume":"137","author":"G Lu","year":"2021","unstructured":"Lu G, Wu Z, Shang J, Xie Z, Chen C, Zhang C (2021) The effects of metformin on autophagy. Biomed Pharmacother 137:111286. https:\/\/doi.org\/10.1016\/j.biopha.2021.111286","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1745_CR55","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/nyas.12098","volume":"1281","author":"RC Ma","year":"2013","unstructured":"Ma RC, Chan JC (2013) Type 2 diabetes in East asians: similarities and differences with populations in Europe and the united States. Ann N Y Acad Sci 1281(1):64\u201391. https:\/\/doi.org\/10.1111\/nyas.12098","journal-title":"Ann N Y Acad Sci"},{"key":"1745_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-014-0179-6","volume":"3","author":"M Maurer","year":"2015","unstructured":"Maurer M, Bougoin S, Feferman T, Frenkian M, Bismuth J, Mouly V, Clairac G, Tzartos S, Fadel E, Eymard B, Fuchs S, Souroujon MC, Berrih-Aknin S (2015) IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis. Acta Neuropathol Commun 3:1. https:\/\/doi.org\/10.1186\/s40478-014-0179-6","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"1745_CR57","doi-asserted-by":"publisher","DOI":"10.1212\/cpj.0000000000200503","volume":"15","author":"NP McLaren","year":"2025","unstructured":"McLaren NP, Roy B, Nowak RJ (2025) Understanding racial and ethnic disparities in myasthenia Gravis outcomes: EXPLORE-MG registry experience. Neurol Clin Pract 15(4):e200503. https:\/\/doi.org\/10.1212\/cpj.0000000000200503","journal-title":"Neurol Clin Pract"},{"issue":"1","key":"1745_CR58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s13760-019-01102-w","volume":"120","author":"UK Misra","year":"2020","unstructured":"Misra UK, Kalita J, Singh VK, Kumar S (2020) A study of comorbidities in myasthenia gravis. Acta Neurol Belg 120(1):59\u201364. https:\/\/doi.org\/10.1007\/s13760-019-01102-w","journal-title":"Acta Neurol Belg"},{"key":"1745_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.102066","volume":"91","author":"SY Ng","year":"2025","unstructured":"Ng SY, Mikhail AI, Mattina SR, Mohammed SA, Khan SK, Desjardins EM, Lim C, Phillips SM, Steinberg GR, Ljubicic V (2025) AMPK regulates the maintenance and remodelling of the neuromuscular junction. Mol Metab 91:102066. https:\/\/doi.org\/10.1016\/j.molmet.2024.102066","journal-title":"Mol Metab"},{"issue":"19","key":"1745_CR60","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.2169\/internalmedicine.8772-21","volume":"61","author":"R Ono","year":"2022","unstructured":"Ono R, Iwai Y, Yamazaki T, Takahashi H, Hori Y, Fukushima K, Saotome T (2022) Nivolumab-induced myositis and myocarditis with positive anti-titin antibody and anti-voltage-gated potassium channel Kv1.4 antibody. Intern Med 61(19):2973\u20132979. https:\/\/doi.org\/10.2169\/internalmedicine.8772-21","journal-title":"Intern Med"},{"issue":"4","key":"1745_CR61","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.cmet.2015.02.017","volume":"21","author":"A Ortega-Molina","year":"2015","unstructured":"Ortega-Molina A, Lopez-Guadamillas E, Mattison JA, Mitchell SJ, Mu\u00f1oz-Martin M, Iglesias G, Gutierrez VM, Vaughan KL, Szarowicz MD, Gonz\u00e1lez-Garc\u00eda I, L\u00f3pez M, Cebri\u00e1n D, Martinez S, Pastor J, de Cabo R, Serrano M (2015) Pharmacological Inhibition of PI3K reduces adiposity and metabolic syndrome in obese mice and rhesus monkeys. Cell Metab 21(4):558\u2013570. https:\/\/doi.org\/10.1016\/j.cmet.2015.02.017","journal-title":"Cell Metab"},{"key":"1745_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041743","author":"NV Popova","year":"2021","unstructured":"Popova NV, J\u00fccker M (2021) The role of mTOR signaling as a therapeutic target in cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22041743","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1745_CR63","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1089\/met.2023.0125","volume":"21","author":"D Prone-Olazabal","year":"2023","unstructured":"Prone-Olazabal D, Davies I, Gonz\u00e1lez-Galarza FF (2023) Metabolic syndrome: an overview on its genetic associations and gene-diet interactions. Metab Syndr Relat Disord 21(10):545\u2013560. https:\/\/doi.org\/10.1089\/met.2023.0125","journal-title":"Metab Syndr Relat Disord"},{"issue":"3","key":"1745_CR64","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/febs.16306","volume":"290","author":"JM Sanches","year":"2023","unstructured":"Sanches JM, Zhao LN, Salehi A, Wollheim CB, Kaldis P (2023) Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk. FEBS J 290(3):620\u2013648. https:\/\/doi.org\/10.1111\/febs.16306","journal-title":"FEBS J"},{"key":"1745_CR65","doi-asserted-by":"publisher","DOI":"10.1172\/jci164486","author":"JA Schaub","year":"2023","unstructured":"Schaub JA, AlAkwaa FM, McCown PJ, Naik AS, Nair V, Eddy S, Menon R, Otto EA, Demeke D, Hartman J, Fermin D, O\u2019Connor CL, Subramanian L, Bitzer M, Harned R, Ladd P, Pyle L, Pennathur S, Inoki K, Bjornstad P (2023) SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes. J Clin Invest. https:\/\/doi.org\/10.1172\/jci164486","journal-title":"J Clin Invest"},{"issue":"1","key":"1745_CR66","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12020-024-04143-1","volume":"88","author":"T Shao","year":"2025","unstructured":"Shao T, Lu J, Kang H, Zhang Y, Lan T, Wang J (2025) Diabetes mellitus in patients with myasthenia gravis: a systematic review and meta-analysis. Endocrine 88(1):24\u201335. https:\/\/doi.org\/10.1007\/s12020-024-04143-1","journal-title":"Endocrine"},{"key":"1745_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ph15080912","author":"V Sorrenti","year":"2022","unstructured":"Sorrenti V, Benedetti F, Buriani A, Fortinguerra S, Caudullo G, Davinelli S, Zella D, Scapagnini G (2022) Immunomodulatory and antiaging mechanisms of resveratrol, rapamycin, and metformin: focus on mTOR and AMPK signaling networks. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph15080912","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"1745_CR68","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","volume":"24","author":"GR Steinberg","year":"2023","unstructured":"Steinberg GR, Hardie DG (2023) New insights into activation and function of the AMPK. Nat Rev Mol Cell Biol 24(4):255\u2013272. https:\/\/doi.org\/10.1038\/s41580-022-00547-x","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9467","key":"1745_CR69","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/s0140-6736(05)61032-x","volume":"365","author":"M Stumvoll","year":"2005","unstructured":"Stumvoll M, Goldstein BJ, van Haeften TW (2005) Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365(9467):1333\u20131346. https:\/\/doi.org\/10.1016\/s0140-6736(05)61032-x","journal-title":"Lancet"},{"key":"1745_CR70","doi-asserted-by":"crossref","unstructured":"Suryadevara V, Habab Y, Hutcheson A, Panjiyar B, Davydov G, Nashat H, Ghali S, Afifi S, Khan S (2023) Comparing Safety and Efficacy of Rituximab and Eculizumab in Treating Refractory Myasthenia Gravis: A Systematic Review. J Int Med Graduates 2(2)","DOI":"10.56570\/jimgs.v2i2.138"},{"issue":"2","key":"1745_CR71","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/25785826.2025.2472449","volume":"48","author":"S Suzuki","year":"2025","unstructured":"Suzuki S (2025) Pathogenesis and detection methods of anti-acetylcholine receptor antibodies in myasthenia gravis. Immunol Med 48(2):117\u2013123. https:\/\/doi.org\/10.1080\/25785826.2025.2472449","journal-title":"Immunol Med"},{"issue":"3","key":"1745_CR72","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","volume":"101","author":"A Szwed","year":"2021","unstructured":"Szwed A, Kim E, Jacinto E (2021) Regulation and metabolic functions of mTORC1 and mTORC2. Physiol Rev 101(3):1371\u20131426. https:\/\/doi.org\/10.1152\/physrev.00026.2020","journal-title":"Physiol Rev"},{"issue":"8","key":"1745_CR73","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/cbin.12189","volume":"48","author":"R Taheri","year":"2024","unstructured":"Taheri R, Mokhtari Y, Yousefi AM, Bashash D (2024) The PI3K\/Akt signaling axis and type 2 diabetes mellitus (T2DM): from mechanistic insights into possible therapeutic targets. Cell Biol Int 48(8):1049\u20131068. https:\/\/doi.org\/10.1002\/cbin.12189","journal-title":"Cell Biol Int"},{"key":"1745_CR74","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/b978-0-12-823912-4.00026-8","volume":"200","author":"MR Tannemaat","year":"2024","unstructured":"Tannemaat MR, Huijbers MG, Verschuuren J (2024) Myasthenia gravis-Pathophysiology, diagnosis, and treatment. Handb Clin Neurol 200:283\u2013305. https:\/\/doi.org\/10.1016\/b978-0-12-823912-4.00026-8","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"1745_CR75","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1600-0404.2006.00649.x","volume":"114","author":"C Toth","year":"2006","unstructured":"Toth C, McDonald D, Oger J, Brownell K (2006) Acetylcholine receptor antibodies in myasthenia Gravis are associated with greater risk of diabetes and thyroid disease. Acta Neurol Scand 114(2):124\u2013132. https:\/\/doi.org\/10.1111\/j.1600-0404.2006.00649.x","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"1745_CR76","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cmet.2006.05.003","volume":"3","author":"SH Um","year":"2006","unstructured":"Um SH, D\u2019Alessio D, Thomas G (2006) Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 3(6):393\u2013402. https:\/\/doi.org\/10.1016\/j.cmet.2006.05.003","journal-title":"Cell Metab"},{"issue":"1","key":"1745_CR77","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4161\/auto.7.1.13883","volume":"7","author":"L Vucicevic","year":"2011","unstructured":"Vucicevic L, Misirkic M, Janjetovic K, Vilimanovich U, Sudar E, Isenovic E, Prica M, Harhaji-Trajkovic L, Kravic-Stevovic T, Bumbasirevic V, Trajkovic V (2011) Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent Blockade of Akt\/mTOR pathway. Autophagy 7(1):40\u201350. https:\/\/doi.org\/10.4161\/auto.7.1.13883","journal-title":"Autophagy"},{"issue":"2","key":"1745_CR78","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/qjmed\/hcad225","volume":"117","author":"J Wang","year":"2024","unstructured":"Wang J, Zhou H, Chen H, Feng H, Chang T, Sun C, Guo R, Ruan Z, Bi F, Li J, Wang J, Wang K, Ma G, Lei S, Wang C, Wang Z, Huang F, Zhang S, Wen Q, Da Y (2024a) Environmental factors affecting the risk of generalization for ocular-onset myasthenia gravis: a nationwide cohort study. QJM 117(2):109\u2013118. https:\/\/doi.org\/10.1093\/qjmed\/hcad225","journal-title":"QJM"},{"key":"1745_CR79","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S465713","author":"Z Wang","year":"2024","unstructured":"Wang Z, Xu J, Mo L, Zhan R, Zhang J, Liu L, Jiang J, Zhang Y, Bai Y (2024b) The application potential of the regulation of Tregs function by Irisin in the prevention and treatment of immune-related diseases. Drug Des Devel Ther. https:\/\/doi.org\/10.2147\/DDDT.S465713","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"1745_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23745","volume":"10","author":"SL Wei","year":"2024","unstructured":"Wei SL, Yang CL, Si WY, Dong J, Zhao XL, Zhang P, Li H, Wang CC, Zhang M, Li XL, Duan RS (2024) Altered serum levels of cytokines in patients with myasthenia Gravis. Heliyon 10(1):e23745. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23745","journal-title":"Heliyon"},{"issue":"1","key":"1745_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-023-03406-0","volume":"23","author":"H Wilcke","year":"2023","unstructured":"Wilcke H, Glaubitz S, K\u00fcck F, Anten C, Liebetanz D, Schmidt J, Zsch\u00fcntzsch J (2023) Female sex and overweight are associated with a lower quality of life in patients with myasthenia gravis: a single center cohort study. BMC Neurol 23(1):366. https:\/\/doi.org\/10.1186\/s12883-023-03406-0","journal-title":"BMC Neurol"},{"issue":"3","key":"1745_CR82","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s12020-023-03539-9","volume":"83","author":"P Wu","year":"2024","unstructured":"Wu P, Song Y, Chen Z, Xia J, Zhou Y (2024) Changes of B cell subsets in different types of diabetes and its effect on the progression of latent autoimmune diabetes in adults. Endocrine 83(3):624\u2013635","journal-title":"Endocrine"},{"issue":"2","key":"1745_CR83","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/ane.12374","volume":"132","author":"JH Yeh","year":"2015","unstructured":"Yeh JH, Chen HJ, Lin CC, Chen YK, Chiu HC, Kao CH (2015) Risk of diabetes mellitus among patients with myasthenia Gravis. Acta Neurol Scand 132(2):132\u2013138. https:\/\/doi.org\/10.1111\/ane.12374","journal-title":"Acta Neurol Scand"},{"issue":"10","key":"1745_CR84","doi-asserted-by":"publisher","first-page":"e975","DOI":"10.1212\/wnl.0000000000012463","volume":"97","author":"Z Yu","year":"2021","unstructured":"Yu Z, Zhang M, Jing H, Chen P, Cao R, Pan J, Luo B, Yu Y, Quarles BM, Xiong W, Rivner MH, Mei L (2021) Characterization of LRP4\/Agrin antibodies from a patient with myasthenia gravis. Neurology 97(10):e975\u2013e987. https:\/\/doi.org\/10.1212\/wnl.0000000000012463","journal-title":"Neurology"},{"issue":"12","key":"1745_CR85","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.70010","volume":"16","author":"AT Zaidalkilani","year":"2024","unstructured":"Zaidalkilani AT, Al-Kuraishy HM, Fahad EH, Al-Gareeb AI, Elewa YHA, Zahran MH, Alexiou A, Papadakis M, Al-Farga A, Batiha GE (2024) Autophagy modulators in type 2 diabetes: a new perspective. J Diabetes 16(12):e70010. https:\/\/doi.org\/10.1111\/1753-0407.70010","journal-title":"J Diabetes"},{"issue":"6","key":"1745_CR86","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.transproceed.2019.04.067","volume":"51","author":"J Zhang","year":"2019","unstructured":"Zhang J, Jin H, Xu Y, Shan J (2019) Rapamycin modulate Treg\/Th17 balance via regulating metabolic pathways: a study in mice. Transplant Proc 51(6):2136\u20132140. https:\/\/doi.org\/10.1016\/j.transproceed.2019.04.067","journal-title":"Transplant Proc"},{"issue":"1","key":"1745_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02298-6","volume":"18","author":"P Zhang","year":"2021","unstructured":"Zhang P, Yang CL, Du T, Liu YD, Ge MR, Li H, Liu RT, Wang CC, Dou YC, Duan RS (2021) Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity. J Neuroinflammation 18(1):244. https:\/\/doi.org\/10.1186\/s12974-021-02298-6","journal-title":"J Neuroinflammation"},{"key":"1745_CR88","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.molimm.2018.03.008","volume":"97","author":"J Zhou","year":"2018","unstructured":"Zhou J, Wang Y, He Y, Gao Y, Wan R, Cai M, Li W, Chen R, Walker E, Zhai X, Wang Q (2018) Non-obese type 2 diabetes patients present intestinal B cell dysregulations associated with hyperactive intestinal Tfh cells. Mol Immunol 97:27\u201332. https:\/\/doi.org\/10.1016\/j.molimm.2018.03.008","journal-title":"Mol Immunol"},{"issue":"20","key":"1745_CR89","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.1021\/acs.jafc.1c01109","volume":"69","author":"YJ Zhou","year":"2021","unstructured":"Zhou YJ, Xu N, Zhang XC, Zhu YY, Liu SW, Chang YN (2021) Chrysin improves glucose and lipid metabolism disorders by regulating the AMPK\/PI3K\/AKT signaling pathway in Insulin-Resistant HepG2 cells and HFD\/STZ-induced C57BL\/6J mice. J Agric Food Chem 69(20):5618\u20135627. https:\/\/doi.org\/10.1021\/acs.jafc.1c01109","journal-title":"J Agric Food Chem"},{"key":"1745_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1223322","volume":"14","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Wang B, Hao Y, Zhu R (2023) Clinical features of myasthenia Gravis with neurological and systemic autoimmune diseases. Front Immunol 14:1223322. https:\/\/doi.org\/10.3389\/fimmu.2023.1223322","journal-title":"Front Immunol"},{"key":"1745_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.756493","volume":"12","author":"J Zhuang","year":"2021","unstructured":"Zhuang J, Guan M, Liu M, Liu Y, Yang S, Hu Z, Lai F, He F (2021) Immune-related molecular profiling of thymoma with myasthenia gravis. Front Genet 12:756493. https:\/\/doi.org\/10.3389\/fgene.2021.756493","journal-title":"Front Genet"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01745-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-025-01745-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01745-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:12:34Z","timestamp":1767492754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-025-01745-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":90,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1745"],"URL":"https:\/\/doi.org\/10.1007\/s11011-025-01745-0","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}},{"value":"The authors declare no competing financial interests or personal relationships.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"329"}}